TissueLabs: Funding, Investors & Team (Sep 2026)
TissueLabs is the platform for creating organs and tissues in the lab. We offer biomaterials, equipment, and services to support tissue engineering and regenerative medicine. Our products are created to allow performing state-of-the-art research, from drug discovery to organ fabrication. Currently, we are focused on attending the academic life sciences market. In the future, our mission is to fabricate lab-grown tissues and organs, for both research and therapeutic applications.
TissueLabs has raised $1.9M across 3 funding rounds on record, the most recent an undisclosed round of $800k announced in Mar 2024.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
TissueLabs Company Profile and Key Stats
Latest funding round on record: Mar 2024.
TissueLabs Funding Rounds
TissueLabs raised $1.0M in an undisclosed round announced in Dec 2020.
9 months later, a Grant of $100k was announced in Sep 2021.
2.5 years later, an undisclosed round of $800k was announced in Mar 2024.
TissueLabs Founders and Leadership Team
Contact details for the TissueLabs team: 1 of 1 has an email address on file.
Start 14-day free trial →TissueLabs Funding Compared to Other Biotechnology Startups
TissueLabs' latest round of $800k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like TissueLabs in Biotechnology and Manno
Companies Similar to TissueLabs
Adaptyv Biosystems developing a protein engineering platform using cell-free synthetic biology and…
At Immitra Bio, we are developing a unique genetic medicine platform that combines two of the most powerful…
compliag is providing agile solutions for regulated industries, including the licencing, manufacturing and…
MoonLake Immunotherapeutics is a biopharmaceutical company in the clinical stage that is developing new…
Isospec Analytics SA is a life science company that aims at simplifying molecular identification. We are…
Cria Technologies reinvents cold-chain transport with high-vacuum insulation technology that offers…
Precise Health is a phage therapy platform that specialises in improving and treating bacterial infections to…
AC Immune is a biopharmaceutical company based in Switzerland that is currently in the clinical stage. They…
AlveoliX provides in-vitro solutions based on proprietary and unique organ-on-chip technologies aimed at…
Combioxin SA is clinical-stage biotech company developing innovative anti-virulence drugs to treat severe…
MindMaze is a digital neurotherapeutic platform that provides digital assessments and therapeutics to treat…
Neurosoft Bioelectronics is developing next-generation soft implantable electrodes to interface with the…
TissueLabs Funding FAQs
What does TissueLabs do?
TissueLabs is the platform for creating organs and tissues in the lab. We offer biomaterials, equipment, and services to support tissue engineering and regenerative medicine. Our products are created to allow performing state-of-the-art research, from drug discovery to organ fabrication. Currently, we are focused on attending the academic life sciences market. In the future, our mission is to fabricate lab-grown tissues and organs, for both research and therapeutic applications.
How much funding has TissueLabs raised?
TissueLabs has raised $1.9M across 3 rounds on record. The most recent is an undisclosed round of $800k announced in Mar 2024.
When did TissueLabs last raise funding?
TissueLabs' most recent funding round on record is an undisclosed round of $800k, announced in Mar 2024.
Who is the CEO of TissueLabs?
Gabriel Liguori is listed as CEO at TissueLabs.
Where is TissueLabs headquartered?
TissueLabs is based in Manno, Ticino, Switzerland.
How many employees does TissueLabs have?
TissueLabs is in the 11-50 employee band.
How does TissueLabs' funding compare to other Biotechnology startups?
TissueLabs' latest round of $800k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's TissueLabs Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for TissueLabs is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.